Discover
MIRA
MIRA Pharmaceuticals, Inc.
0.77
2 x 0.53
2 x 1.01
bid
ask
+
0.02
2.52%
12:28 PM
timesize
| Ytd | -49.07% | |
| 1y | -43.87% |
0.75
day range
0.77
0.60
52 week range
2.45
| Open | 0.75 | Prev Close | 0.75 | Low | 0.75 | High | 0.77 | Mkt Cap | 32.31M |
| Vol | 22.20K | Avg Vol | 83.80K | EPS | -1.22 | P/E | N/A | Forward P/E | -2.14 |
| Beta | 1.54 | Short Ratio | 0.47 | Inst. Own | 5.96% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | N/A | 50-d Avg | 0.85 | 200-d Avg | 1.13 | 1yr Est | 12.08 |
| Income Statement | |||
| Operating Expenses | 1.16M | ||
| Research and Development Expense | 705.79K | ||
| Selling, General and Administrative Expense | 450.33K | ||
| Operating Income | -1.16M | ||
| Net Income | -1.21M | ||
| Net Income Common Stock | -1.21M | ||
| Net Income Common Stock (USD) | -1.21M | ||
| Consolidated Income | -1.21M | ||
| Earnings per Basic Share | -0.03 | ||
| Earnings per Basic Share (USD) | -0.03 | ||
| Earnings per Diluted Share | -0.03 | ||
| Earning Before Interest & Taxes (EBIT) | -1.21M | ||
| Earning Before Interest & Taxes (USD) | -1.21M | ||
| Weighted Average Shares | 42.02M | ||
| Weighted Average Shares Diluted | 42.02M | ||
| Balance Sheet | |||
| Cash and Equivalents | 3.61M | ||
| Cash and Equivalents (USD) | 3.61M | ||
| Investments | 4.50M | ||
| Investments Current | 4.50M | ||
| Trade and Non-Trade Receivables | 35.44K | ||
| Current Assets | 8.17M | ||
| Total Assets | 8.20M | ||
| Current Liabilities | 40.82K | ||
| Total Liabilities | 40.82K | ||
| Accumulated Retained Earnings (Deficit) | -41.94M | ||
| Shareholders Equity | 8.16M | ||
| Shareholders Equity (USD) | 8.16M | ||
| Assets Non-Current | 35.44K | ||
| Trade and Non-Trade Payables | 40.82K | ||
| Cash Flow | |||
| Net Cash Flow / Change in Cash & Cash Equivalents | -1.21M | ||
| Net Cash Flow from Operations | -1.21M | ||
| Share Based Compensation | 21.88K | ||